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Background: We propose a new approach to facilitate sentinel node biopsy examination by multimodality imaging
in which radioactive and near-infrared (NIR) fluorescent nanoparticles depict deeply situated sentinel nodes and
fluorescent nodes with anatomical resolution in the surgical field. For this purpose, we developed polyamidoamine
(PAMAM)-coated silica nanoparticles loaded with technetium-99m (99mTc) and indocyanine green (ICG).
Methods: We conducted animal studies to test the feasibility and utility of this dual-modality imaging probe. The
mean diameter of the PAMAM-coated silica nanoparticles was 30 to 50 nm, as evaluated from the images of
transmission electron microscopy and scanning electron microscopy. The combined labeling with 99mTc and ICG
was verified by thin-layer chromatography before each experiment. A volume of 0.1 ml of the nanoparticle solution
(7.4 MBq, except for one rat that was injected with 3.7 MBq, and 1 μg of an ICG derivative [ICG-sulfo-OSu]) was
injected submucosally into the tongue of six male Wistar rats.
Results: Scintigraphic images showed increased accumulation of 99mTc in the neck of four of the six rats. Nineteen
lymph nodes were identified in the dissected neck of the six rats, and a contact radiographic study showed three
nodes with a marked increase in uptake and three nodes with a weak uptake. NIR fluorescence imaging provided
real-time clear fluorescent images of the lymph nodes in the neck with anatomical resolution. Six lymph nodes
showed weak (+) to strong (+++) fluorescence, whereas other lymph nodes showed no fluorescence. Nodes
showing increased radioactivity coincided with the fluorescent nodes. The radioactivity of 15 excised lymph nodes
from the four rats was assayed using a gamma well counter. Comparisons of the levels of radioactivity revealed a
large difference between the high-fluorescence-intensity group (four lymph nodes; mean, 0.109% ± 0.067%) and
the low- or no-fluorescence-intensity group (11 lymph nodes; mean, 0.001% ± 0.000%, p < 0.05). Transmission
electron microscopy revealed that small black granules were localized to and dispersed within the cytoplasm of
macrophages in the lymph nodes.
Conclusion: Although further studies are needed to determine the appropriate dose of the dual-imaging
nanoparticle probe for effective sensitivity and safety, the results of this animal study revealed a novel method for
improved node detection by a dual-modality approach for sentinel lymph node biopsy.
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Sentinel lymph node biopsy has been widely used in
cancer treatment to assess lymph node metastasis at
early stages. It has been reported that this procedure has
an accuracy rate greater than 95% in the evaluation of
lymph node metastasis in patients with stage N0 carcin-
oma, especially in patients with malignant melanoma or
breast carcinoma. Sentinel lymph nodes are those that
directly drain a primary tumor, and metastatic cells are
likely to spread to and lodge in the sentinel lymph node
(s) first. Therefore, precise examination of the sentinel
lymph node can accurately predict the lymph node sta-
tus of the entire lymph basin at early stages of cancer
progression.
Before a biopsy is taken, lymphoscintigraphy (senti-
nel lymph node mapping) is performed to identify the
pattern of the lymphatic drainage and the sentinel
lymph nodes associated with the primary tumor.
Lymphoscintigraphy can reveal unexpected lymphatic
vessels and lymph nodes associated with different
lymphatic drainage basins. Surgeons trace the sentinel
lymph node using a gamma probe that can provide
radioactivity counts. Variable-pitch audio output is
based on the intensity of the radioactivity and is
detected in the operating theater. As surgeons are un-
able to visualize increased radioactivity with spatial
resolution, a small gamma camera can be used for this
purpose at the time of the biopsy [1]. However, sentinel
lymph nodes with increased accumulation cannot be
defined with anatomical resolution. The blue-dye tech-
nique is often combined with the radioisotope method
to yield greater sentinel lymph node detection [2].
However, the blue-dye technique only offers the
visualization of lymph flow and sentinel nodes within
the incision area. Furthermore, these blue dyes are sol-
uble and are quickly flushed from lymphatic channels.
The lymphatic flow containing the dye may disappear
rapidly from the lymph nodes. When performed alone,
this method has a much lower sentinel lymph node iden-
tification rate compared to lymphoscintigraphy [2].
Attempts to combine several effective techniques have
been reported in animal studies, including the addition
of technetium-99m (99mTc), 125I, or 111In to approaches
using Evans Blue [3], methylene blue [4], phthalocyanine
tetrasulfonate [5], dextran, blue Ficoll dyes, among others.
In addition, a study by Tsopelas et al. [3] reported that
99mTc-Evans Blue was useful for differentiating the initial
draining lymph node from higher-tier nodes in linked
chains. This study also demonstrated the advantage of pro-
viding radioactive and color signals simultaneously during
operative exposure.
Near-infrared (NIR) imaging using indocyanine green
(ICG) was recently introduced as a new option for im-
aging sentinel lymph nodes [6-8]. ICG has a long historyof use in the clinic for testing liver function and cardiac
output and for ophthalmic angiography. Recent studies
have demonstrated the usefulness of ICG fluorescence
imaging during sentinel lymph node biopsy in compari-
son to other visual dyes. This efficacy probably stems
from the advantages of NIR fluorescence, which allows
deeper penetration of photons into living tissue due to
its decreased absorption and scattering and minimal
tissue autofluorescence at the wavelengths utilized [9].
However, tissue penetration is still limited compared to
gamma rays.
Recently, the combination of NIR and radionuclide
imaging was tested to reveal sentinel lymph nodes in
animals. In this method, albumin radiocolloid (99mTc)
and ICG are conjugated for lymphoscintigraphy and
fluorescent imaging simultaneously [10]. This new com-
bined imaging has also been introduced into clinical
settings [11,12]. A successful multimodal sentinel lymph
node imaging with NIR agent (Cy7) covalently labeled
with 99mTc has also been reported in animals [13].
We sought to develop a new approach by silica nano-
particle-based dual-modality imaging to facilitate senti-
nel node biopsy examinations, in which radioactive and
NIR fluorescent nanoparticles are used to depict deeply
situated sentinel nodes and fluorescent nodes and to
enable simultaneous visualization at anatomical reso-
lution within the field of interest. For this purpose, we
developed polyamidoamine (PAMAM)-coated silica
nanoparticles loaded with 99mTc and ICG and conducted
animal studies to test the feasibility and utility of this
dual-modality imaging system.
Methods
We developed PAMAM-coated silica nanoparticles
(PCSNs) loaded with 99mTc radioactivity and NIR fluor-
escent ICG for dual-modality imaging to detect sentinel
lymph nodes in basic and animal studies.
PAMAM-coated silica nanoparticles
These studies were performed using Aerosil 200 syn-
thetic amorphous silica nanoparticles obtained from
Nippon Aerosil, Tokyo, Japan. The particle size, spe-
cific surface area, and silanol group content were 12
nm, 200 m2/g, and 1.37 mmol/g, respectively [14]. The
grafting of hyperbranched PAMAM (generation 3)
onto the silica nanoparticle surface was achieved, as
shown in Figure 1 [15].
The percentage of grafted PAMAM and the amino
group content of the silica nanoparticles used in these
experiments were 55.6% and 3.6 mmol/g, respectively.
The percentage of PAMAM that grafted onto the silica
surface was determined using a previously described
equation [14]. The amino group content on the silica
nanoparticle surface was determined by titration.
Figure 1 PAMAM-coated silica nanoparticles loaded with 99mTc and ICG.
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Twenty milligrams of PCSNs was diluted in 50% ethanol
with distilled water (total volume, 20 ml) and mixed using
an ultrasonic water bath for 30 min. The diluted solution
was filtered using a centrifugal device (ultrafree centrifugal
filter, Durapore PVDF 0.1 μm, Millipore, Billerica, MA,
USA) and a centrifuge with a radius of 15.0 cm (13,000
rpm, 15 min). After separating the smaller particles (less
than 0.1 μm), the filtrates were used for further processing.
99mTc (74 MBq/100 μl) was added to 890 μl of the
filtrate for chelation to the surface of the nanoparticles;
this solution was then incubated for 30 min at 37°C.
One milligram of ICG-sulfo-OSu (2-[7-[1,3-dihydro-1,1-
dimethyl-3-(4-sulfobutyl)-2H-benzo[e]indol-2-ylidene]-
1,3,5-heptatrienyl]-1,1-dimethyl-3-[5-(3-sulfosuccinimi
dyl)oxycarbonylpentyl]-1H-benzo[e] indolium, inner salt,
and sodium salt; Dojindo Laboratories, Kumamoto, Japan)
was dissolved in 1 ml of DMSO (Thermo Scientific,
Hudson, NH, USA). Ten microliters of the ICG-sulfo-OSu
dilution was added to 990 μl of the solution containing the
radiolabeled nanoparticles for N-terminal binding to the
surface of the PCSNs. The solution of nanoparticles, which
was now loaded with radioactivity and fluorescence, was
used as a probe in the subsequent experiments (Figure 1).
The PCSN probe solutions were analyzed by silica concen-
tration measurement. The samples were evaporated to
dryness with an alkali fusion procedure. This was followed
by inductively coupled plasma-atomic emission spectrom-
etry (ICP-AES) (iCAP 6500 Duo, Thermo Fisher Scientific
Inc., Waltham, MA, USA) measurement. The zeta potential
of the prepared PCSN was measured using an automated
electrokinetic analyzer (ELSZ-2N, Otsuka Electronics Co.
Ltd., Osaka, Japan). The measurement was repeated five
times.
Size of PCSNs
The size of the PCSNs prepared was evaluated using a
transmission electron microscope (TEM) and a scanningelectron microscope (SEM; S-800 15kV, Hitachi, Tokyo,
Japan). The size distribution and concentration of the
nanoparticles in the solution were assessed using an
optical particle-size analyzer (SALD-7100, Shimadzu,
Kyoto, Japan).Radioactivity and fluorescence of the PCSN probe
The radioactivity and fluorescence of the labeled PCSNs
were verified with thin-layer chromatography (TLC) util-
izing TLC silica gel 60 F254 (Merck KGaA, Darmstadt,
Germany) with an imaging plate (BAS-SR2040, FujiFilm,
Tokyo, Japan) and using a fluorescence imaging sys-
tem (photodynamic eye (PDE); Hamamatsu Photonics,
Hamamatsu, Japan) or ImageQuant LAS-4000 (GE
Healthcare, Piscataway, NJ, USA). TLC was performed
using 2 μl of the PCSN probe solution applied to the TLC
plate, and the radioactivity and fluorescence were quanti-
fied 25 min later. TLC contact radiography was
performed by placing the TLC plates on the imaging plate
and then scanning them using a phosphor imager FLA-
2000 (FujiFilm, Tokyo, Japan). Fluorescence levels were
visualized from the display.Animal experiments
Six male Wistar rats (weight: mean, 530 g; range, 480 to
560 g; Charles River Breeding Laboratories, Yokohama,
Japan) were anesthetized via an intraperitoneal injection
of sodium pentobarbital (30 to 40 mg/kg) (Somnopentil,
Schering-Plough Animal Health, Omaha, NE, USA).
After the rats had been immobilized on a table, 0.1 ml of
the PCSN probe solution (7.4 MBq, except for one rat
that was injected with 3.7 MBq, and 1 μg ICG) was
injected submucosally into the tongue. Subsequent
scintigraphic studies used a gamma camera (SNC-
5100R, matrix size of 512 × 512 pixels, field of view 51
× 38 cm, parallel-hole low-energy (high resolution) colli-
mator; Shimadzu, Kyoto, Japan). One of the six rats was
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these results were not analyzed.
Lymphoscintigraphy (sequential static images, every 10
min) was performed in all six rats during the first hour after
injection. After completion of the lymphoscintigraphy, the
animals were euthanized via intraperitoneal injection of an
overdose of sodium pentobarbital. Immediately after eu-
thanasia, a skin flap was created to expose the underlying
tissue of the neck. The sentinel nodes were explored with
NIR fluorescence imaging using a PDE fluorescence im-
aging system, which included a digital camera with a
charge-coupled device detector that filtered out light wave-
lengths <820 nm. The resulting fluorescent images were
displayed on a monitor. All lymph nodes with or without
fluorescence were dissected for subsequent examination. In
some rats, a small cadmium telluride (CdTe) gamma cam-
era (SSGC) was used for additional imaging of the sentinel
lymph nodes before dissection. The head of the SSGC
consisted of a ‘pixelized’ CdTe module (32 × 32 individual
elements, total of 1,024 pixels) attached to a collimator
(Acrorad, Tokyo, Japan). The field of view was 44.8 mm ×
44.8 mm [16,17]. The excised lymph nodes were examined
using a PDE imaging system or the LAS 4000 for fluores-
cence imaging. The intensity of the fluorescence was
qualitatively scored as no fluorescence (−), weak (+),
medium (++), or strong (+++).
Autoradiography was performed using FLA-2000 with
an imaging plate (IP). The excised lymph nodes were
weighed and placed on the IP, which was covered with a
sheet of polyvinylidene film. The samples were exposed
on the IP in a darkroom for 5 min to produce autoradio-
graphic images of the radioactivity, and the IP was then
processed to image the radioactivity using the FLA-2000
device.
Radioactivity in the lymph nodes and in a set of
reference samples of 99mTc was assayed using an autowell
gamma system (ARC-370 M, Aloka, Tokyo, Japan).
Radioactivity was corrected for decay time, and it is
expressed as percentages of the activity in the specimens
relative to the initially injected radioactivity. Percentage
variability data are expressed as mean ± SD.
All animals were treated in accordance with the
Ethical Guidelines for Investigations of Experimental
Animals of the Nippon Dental University School of Life
Dentistry at Niigata.
Transmission electron microscopy
Excised specimens were confirmed as lymphatic nodes
using H&E staining and toluidine blue staining. Seven
lymph nodes were examined using a TEM (H-7000,
Hitachi, JEM1010; JEOL, Tokyo, Japan) operated at 80
kV and a JEM2010 TEM (200 kV) equipped with an
energy-dispersive spectroscopy (EDS) system (JEOL,
Tokyo, Japan). Resin blocks were made from formalin-fixed tissue, and semithin and ultrathin sections were
then cut for observation.
Statistics
Two-group comparisons were performed using Welch's
t-test. SPSS software v. 15.0J (IBM SPSS, Tokyo, Japan)
was used for these analyses.
Results
The mean diameter of the PCSNs was 30 to 50 nm as
evaluated by TEM and SEM (Figure 2A,B). The distribu-
tion of the particle sizes was measured using a laser-
scattering particle size analyzer, SALD-7100. The peak of
the distribution was 30 nm in the ethanol solution (50%
water; Figure 2C). Combined labeling of the PCSN
probes with both 99mTc and ICG-sulfo-OSu was verified
by TLC before each experiment. Areas containing 2 μl
of the grafted PCSN probes were visualized for radio-
activity by contact radiography and for fluorescence
using the LAS-4000 in exactly the same location. Flares
caused by free agents were not observed in either of the
confirmation procedures (Figure 2D). The concentration
of silica in the PCSN probe solution was 3 mcg/g (ppm)
by ICP-AES. The mean of the zeta potential of PCSN
was determined to be 8.09 ± 0.24mV (mean ± SD) using
the Smoluchowski equation. Nanoparticles with zeta
potentials greater than +30 mV are considered as
strongly cationic. The PCSN is considered approximately
neutral because the zeta potential is in a range extending
between −10 and +10 mV.
Following the injection of the PCSN probe solution
into the rats, two radiologists observed sequential static
images on a display at 5-min intervals for 1 h per ani-
mal. The scintigraphic images showed a single increased
focus of 99mTc activity in the neck with a markedly in-
creased uptake at the injection site (Figures 3 and 4).
The fixed increase in uptake observed throughout the
study was judged to represent lymph node accumulation.
Other migrating or linear uptake was considered to rep-
resent movement via lymph channels or flow in the
esophagus due to overflow of the PCSN probes at the
site of injection (the tongue). A single increased nodal
uptake was observed in four of the six injected rats in
the final static images. The two remaining animals
showed no increase in uptake; however, for one of these
animals, this observation was probably due to the injec-
tion of an insufficient dose of radioactivity (3.7 MBq of
99mTc as compared with 7.4 MBq in the other rats)
(Table 1).
Skin incisions were made, and 19 lymph nodes were
identified in the six rats (Table 1). The weight (mean ±
SD) of these lymph nodes was 12.95 ± 7.76 mg, and the
mean of the maximum length of the lymph nodes was
5.1 ± 1.7 mm. Following lymph node excision, contact
Figure 2 SEM and TEM images of silica nanoparticles, distribution of particle sizes, and combined labeling. The mean diameter of the
PAMAM-coated silica nanoparticles was 20 to 50 nm, as evaluated by scanning electron microscopy (A) and transmission electron microscopy (B).
The distribution of the particle sizes was measured using a laser-scattering particle-size analyzer (C). The peak of the distribution was 30 nm in
ethanol solution. Combined labeling with both 99mTc and ICG-sulfo-OSu for PCSNs was verified by TLC before each experiment (D). Two-
microliter spots of the grafted PCSNs were visualized on TLC plates for NIR fluorescence imaging (above) and contact radiography (below).
Verification of the complete graft was confirmed by the lack of flares on either plate.
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with marked increases in 99mTc uptake and three nodes
with weak uptake (Figure 5).
After skin flaps were created, all the dissected necks
were also examined by NIR fluorescence imaging. TheFigure 3 Lymphoscintigraphy of the rats and lymph node dissection
solution was injected into the tongue and the left upper limb. Rat B was a
limb; rat A was injected with a smaller volume (3.7 MBq) in the tongue. Th
neck (arrow), with a marked increase in uptake at the site of injection in ra
uptake in the neck with an acquisition time of 30 s (A, right). Lymph nodes
lymph nodes in the neck were observed in real time with anatomical resolPDE system provided clear, real-time fluorescence
images of the lymph nodes in the neck with anatomical
resolution. NIR fluorescence imaging ex vivo was
performed following lymph node excision. The intensity
of the fluorescence was qualitatively evaluated as weakin the neck. Lymphoscintigraphy of the rats (A, left). The nanoparticle
dministered 7.4 MBq of PCSN probes in the tongue and the left upper
e larger injection volume (rat B) revealed an increased uptake in the
t B. A small semiconductor gamma camera clearly displayed the
were dissected from the neck of rat B (B, left). Distinct ICG fluorescent
ution (B, right).
Figure 4 Lymph nodes from the dissected neck and serial scintigraphy. Four lymph nodes are shown from the dissected neck of a rat (A,
upper left). Only one lymph node was observed as fluorescent in the dissected neck (A, upper right). Four lymph nodes were excised (A, lower
left). Fine spatial distribution of the fluorescence was observed in one of the four lymph nodes (A, lower right). Serial scintigraphy of a rat after
PCSN probe injection. Increased neck accumulation was observed at 10, 20, 30, 40, 50, and 60 min after injection; these time points are
numbered 1 to 6, respectively (B).
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demonstrated weak (+) to strong (+++) fluorescence,
and the other lymph nodes showed no fluorescence (−)
(Table 1). The precise distribution of the fluorescence
was observed inside some of the excised lymph nodes.
In one of the rats (rat C), no fluorescent lymph nodes
were found in the neck, but faint diffuse fluorescence
was observed throughout the cervical soft tissue. In
addition, no fluorescent nodes were detected in the
neck of rat A due to insufficient injection of labeled
probes. For the nodes examined, increased radioactivity
was associated with increased fluorescence intensity.
The radioactivity of 15 excised lymph nodes from four
rats was assayed using a gamma well counter. The
lymph nodes of rats A and B were not assayed; there
was no specific reason for these animals not being evalu-
ated. The radioactivity of the excised lymph nodes
relative to the initially injected radioactivity (7.4 MBq of
99mTc) ranged from 0.231% to 0.000% (Table 2). The 15
excised lymph nodes were divided into two groups
according to the intensity of their fluorescence. A
comparison of the levels of radioactivity revealed a large
difference between the high-fluorescence-intensity group
(four lymph nodes; mean, 0.109% ± 0.067%; range,
0.231% to 0.006%) and the no-fluorescence-intensity
group (11 lymph nodes; mean, 0.001% ± 0.000%; range,
0.004% to 0.000%). The difference in the means of the
fluorescence intensities for the two groups was statisti-
cally significant (p < 0.05) (Figure 6).
Regarding the localization of the silica nanoparticles,
TEM revealed that small electron-dense granules were
localized to the macrophages in seven lymph nodes. The
appearance of small spherical granules, 10 to 20 nm in
diameter, was restricted to phagosomes of macrophages
and was not observed in other lymphatic cells. EDS re-
vealed a Si peak, which suggested that these granules
were made of silicon (Figure 7).Discussion
There are several advantages to using silica nano-
particle-based dual-modality 99mTc/ICG NIR imaging.
Preoperative lymphoscintigraphy can reveal deeply situ-
ated sentinel lymph nodes, and intraoperative NIR fluor-
escence imaging provides simultaneous visualization at
anatomical resolution in the surgical field following a
single injection. These features may facilitate the sentinel
lymph node biopsy procedure. Furthermore, it is well
known that ambiguous lymphatic drainage results in
atypical sentinel lymph node locations [2,18]. Neverthe-
less, in the cases of unpredictable lymph node drainage
basins, surgeons are capable of identifying the sentinel
lymph nodes by preoperative lymphoscintigraphy and/or
intraoperative surveillance using radiation with greater
penetration. In this study, the sentinel lymph nodes were
imaged using both radioactivity and NIR fluorescence in
the surgical field.
The current study used dual-modality imaging with
PCSN probes labeled with 99mTc and NIR fluorescence to
evaluate sentinel lymph nodes in the recipient animals. The
results demonstrate the potential for these approaches to
detect sentinel lymph nodes during clinical biopsy proce-
dures. However, in this animal imaging study, the concen-
tration of the imaging agents substantially affected the
image quality. Similarly, it has been reported that very little
radioactivity accumulates in the sentinel lymph nodes of
human patients [19]. For example, in breast cancer speci-
mens, the administered activities range from 10 to 108
MBq [19]. Although the injected radiopharmaceuticals and
the timing of the measurements were different, the mean
percentages of the injected doses per lymph node were
reported to be 0.9% [20] and 0.60% [21] in patients with
breast cancer and 0.34% to 0.92% in studies of cutaneous
melanoma [22,23].
In one rabbit study, 5% to 9% (198Au-colloid and
99mTc-antimony sulfur colloid) of the injected dose per
Table 1 Summary of the lymphoscintigraphy, contact





Neck uptake Accumulation Intensity
Rat A (−) (−)
Rat A (−) (−)
Rat B (+) 1, (+) (+++)
Rat B 2, (+) (+)
Rat C 1, (−) (−)
Rat C 2, (−) (−)
Rat C 3, (−) (−)
Rat D 1, (−) (−)
Rat D 2, (slight) (+)
Rat D (+) 3, (+) (++)
Rat D 4, (−) (−)
Rat E (+) 1, (slight) (+)
Rat E 2, (−) (−)
Rat E 3, (−) (−)
Rat E 4, (−) (−)
Rat F 1, (−) (−)
Rat F (+) 2, (slight) (++)
Rat F 3, (−) (−)
Rat F 4, (−) (−)
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18.5 MBq of 99mTc-phytate, the percentage of the
injected dose was 0.21% ± 0.18% (mean ± SD) for lymph
nodes in the neck (ranging from 0.01% to 0.62%) [17]. In
the current rat study, nodes showing increased uptake
contained 0.109% ± 0.067% (mean % per node) of the
initial dose of 7.4 MBq. We estimated that, on average,Figure 5 Excised lymph nodes from rats B and D and contact radiogr
nodes were fluorescent (A, center). Contact radiography indicated that the node
fluorescence (A, right). Four excised lymph nodes of rat D are shown (B, left). Tw
fluorescence was observed in the lymph nodes (B, center). Contact radiography
nodes (B, right).approximately 7.4 KBq of activity accumulated per node.
Although this activity is quite small in comparison to
that used in clinical practice, the sentinel lymph nodes
were accurately visualized using this dose. However,
higher doses of 99mTc would have provided much clearer
images of the lymph nodes.
We used an NIR imaging video camera system for the
in vivo imaging; this system has an excitation wavelength
of 760 nm and a fluorescence emission wavelength of
820 nm. Before each imaging study, we confirmed that
dissolved ICG-sulfo-OSu had bound to the nanoparticles
by TLC to verify the absence of free binding spots or
flares of fluorescence. The rats were administered a sin-
gle 0.1-ml submucosal injection of the PCSN probes
containing 0.9 μg of ICG-sulfo-OSu. In previous clinical
studies, 2.5 mg of ICG was injected for sentinel lymph
node mapping using only NIR fluorescence [6,25]. Fur-
thermore, the injection volume was approximately 21-
to 210-fold larger than the volume used in our animal
experiments. This comparison was calculated using
weights of 60 kg for human subjects and 500 g for rats.
In addition, the amount injected into the rats was also
much less than the amount used in other animal sentinel
lymph node studies [26]. However, the comparatively
small amount of both the 99mTc and the ICG agents
used with the PCSN probes in this study depicted the
sentinel lymph nodes successfully.
For sentinel lymph node detection, the size of the
radiopharmaceutical is critical for optimal imaging. Mul-
tiple sizes have been used for sentinel node detection,
including approximately 50- to 100-nm radiolabeled
colloid, 50- to 200-nm 99mTc-sulfur colloid, or 4- to 100-
nm (95% of the particles <80 nm) 99mTc-nanocolloid of
human serum albumin [2]. The PCSN size used in the
current study was approximately 30 nm, which is withinaphy. Two excised lymph nodes from rat B are shown (A, left). Both lymph
s showing increased radioactivity also demonstrated increased levels of
o of the four lymph nodes were fluorescent. Fine spatial distribution of the
indicated a high level of accumulation of 99mTc in the fluorescent lymph
Table 2 The percentage of radioactivity in excised lymph
nodes relative to the initial injected radioactivity
Lymph node Radioactivity count %/dose
Rat C, 1 192.7 ± 6.7 0.001
Rat C, 2 47.3 ± 9.5 0.000
Rat C, 3 1,189.7 ± 31.8 0.004
Rat D, 1 61.3 ± 1.5 0.000
Rat D, 2 6,528.7 ± 135.4 0.020
Rat D, 3 73,784.3 ± 1,043.8 0.231
Rat D, 4 28.3 ± 5.1 0.000
Rat E, 1 13,293.7 ± 451.0 0.012
Rat E, 2 12.3 ± 2.5 0.000
Rat E, 3 10.0 ± 3.0 0.000
Rat E, 4 12.7 ± 0.6 0.000
Rat F, 1 472.7 ± 21.2 0.000
Rat F, 2 6,745.7 ± 392.6 0.006
Rat F, 3 19.7 ± 2.5 0.000
Rat F, 4 10.7 ± 6.7 0.000
Radioactivity was assayed at different times post-injection in rats C, D, E,
and F.
Figure 6 Fifteen excised lymph nodes were divided into two
groups based on their fluorescence intensity. The radioactivity
of the excised lymph nodes relative to the initial injected
radioactivity was compared between the high-fluorescence
-intensity group (four lymph nodes) and the no-fluorescence
-intensity group (11 lymph nodes). The high-fluorescence group
also exhibited a high percentage of radioactivity (p < 0.05).
Figure 7 Toluidine blue staining, TEM of a macrophage, and
Energy-dispersive spectroscopy. Toluidine blue staining shows a
blood vessel and macrophages in a lymph node (A). TEM of a
macrophage (C, D). High-power images revealed small, black
granules in the macrophages. The granules of approximately 10
nm in diameter concentrated in the phagosomes with a
neighboring mitochondria that did not contain granules inside
(shown at the lower left corner of the panel C). There were also
very few granules in the surrounding cellular components (C).
Energy-dispersive spectroscopy of TEM. The arrow shows a Si
(silicate) peak (B).
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cals have been shown to accumulate, primarily via
phagocytosis, in macrophages lining the sinusoid spaces
in sentinel lymph nodes [2]. It has been reported that
silica-coated fluorescent nanoparticles with a 40-nm
diameter were observed in macrophages and dendritic
cells of sentinel lymph nodes; phagocytosis of these
nanoparticles results in fluorescence enhancement in the
lymph nodes [27]. We also detected PCSNs in macro-
phages, which suggest that retention of these particles
may be the result of macrophage phagocytosis.
Optical imaging is typically limited by tissue penetra-
tion depth and relatively poor quantification. Fluores-
cence imaging is limited to tissue depths of 1 to 2 mm
in the visible range and as much as 1 to 2 cm in the
NIR range [28,29]. Clinically, the detection of the
sentinel lymph node using ICG was restricted to 5 mm
of tissue depth in oropharyngeal cancer patients [30].
With a wavelength ranging from 750 to 1,000 nm,
infrared luminescent light is not directly visible to the
human eye. Hemoglobin, water, lipids, and other
endogenous chromophores, such as melanin, have
their lowest absorption levels within the NIR spectrum,
which permits increased photon depth penetration into
the tissues [31]. Furthermore, in the NIR spectrum, the
autofluorescence emitted from endogenous fluorophores,
such as NADH and porphyrins, is extremely low
compared with UV and visual light wavelengths, which
Tsuchimochi et al. EJNMMI Research 2013, 3:33 Page 9 of 11
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contrast, ICG emits infrared fluorescence.
Successful combined imaging using 99mTc and ICG
fluorescence for sentinel biopsy of the lymph node has
been reported recently [10-12]. Incubation of 99mTc-
nanocolloid and ICG provided a favorable agent retention
time, with the fluorescence lasting up to 19 h post-injection,
for the detection of sentinel lymph nodes in the necks of
patients with squamous cell carcinoma of the oral cavity
[32]. In addition, another new NIR imaging approach to
visualize sentinel lymph nodes has been demonstrated in
animal studies using nano-carriers, such as quantum dots
[31,33-35] and dendrimers [36-38].
Silica nanoparticles have also been used for pre-clinical
in vivo fluorescence imaging [39]; these particles are also
attractive for approaches aiming to integrate multiple
properties for multimodality biomedical imaging [40].
Furthermore, functionalized organically modified silica
nanoparticles can serve as an ideal nano-platform for
the assembly of multimodal nanoparticles for targeted
diagnostics and therapeutics [41]. Benezra et al. used
dye-encapsulating silica particles that were surface-
functionalized with cyclic arginine-glycine-aspartic
acid peptide ligands and radioiodine, which exhibited
high-affinity/avidity binding to αvβ3 integrin in mouse
melanoma [42].
The Aerosil 200 used in this study is an amorphous,
fumed hydrophilic silica. Of the reported nanoparticles
used for imaging, amorphous silica nanoparticles are
feasible materials for in vivo imaging due to their
biocompatible nature compared to other agents, in-
cluding quantum dots, which contain cadmium tellur-
ide crystals. However, it has been reported that
amorphous silica and crystalline silica are phagocy-
tosed and are therefore toxic to mouse alveolar macro-
phage cells. In addition, the inhalation of crystalline
silica has been shown to cause silicosis [43]. Neverthe-
less, the cytotoxicity induced by nano-scale silica
particles is complex and depends on the particle size,
the surface functionalization, and the cell line used for
the study of toxicity [44].
The PCSNs used in this study were functionalized
using PAMAM, which is a type of dendrimer that is
characterized as a branched synthetic molecule com-
posed of spherical nano-structures with a high degree
of molecular uniformity. Importantly, PAMAM pos-
sesses the potential to contribute to in vivo imaging
and drug delivery vehicles as the dendrimer can be
used to generate highly functionalized terminal sur-
faces [45]. We used the terminal NH2 PAMAM for
covalent bonding between the PCSN surfaces and ICG
with simultaneous 99mTc chelation. Thus, our PCSN
probe may help to convey drugs, antibodies, and ligand
molecules by acting as a targeted carrier. It is knownthat the flexibility of dendrimers, along with their size,
charge, and nanoparticle hydrophilicity, influences their
imaging potential by changing their biodistribution and
pharmacokinetics [46]. It is assumed that because our
PCSNs comprise the silica core and surface dendrimers,
the PCSN probes may exhibit stable biological charac-
teristics due to the lower flexibility of the dendrimers in
contrast to probes solely composed of PAMAM
dendrimers. However, how this difference would affect
in vivo imaging is not well known. Further elucidation
will require more study.
Conclusion
In this animal study, surface-functionalized silica
nanoparticles clearly depicted sentinel lymph nodes in
real time with the use of dual-modal imaging using a
low concentration of 99mTc and ICG NIR fluorescence.
This approach may facilitate sentinel lymph node
biopsy procedures, and it represents a novel method
for targeting metastatic cells for imaging and therapy.
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